CASP3基因一个新的功能性SNP rs72689236与川崎病相关性的Meta分析

doi:10.7499/j.issn.1008-8830.2013.06.019

摘要
图/表
参考文献(26)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (1445 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要目的：综合分析半胱氨酸蛋白酶3基因 (CASP3)一个新的功能性单核苷酸多态位点（SNP） rs72689236与川崎病发生发展的相关性。方法：国内外数据库中检索川崎病与CASP3基因相关性研究的文献，根据纳入与排除标准筛选文献，获取2012年11月以前公开发表的病例-对照研究与家系传递不平衡研究（TDT）的资料，结合作者的相关研究结果，评价质量后采用RevMan 5.1软件进行Meta分析。结果：川崎病患者中rs72689236的A等位基因频率显著增高（P<0.001，OR=1.34，95% CI：1.24~1.46)。rs72689236风险等位基因A的携带者（AG+AA）相较于GG个体，患病风险增加约44% （P<0.001, OR=1.44，95% CI：1.27~1.65）。该SNP的风险等位基因A增加了川崎病并发冠状动脉损伤的风险（P=0.01, OR=1.51，95% CI：1.10~2.07），携带风险等位基因A的川崎病患者相比于非携带者，并发冠状动脉损伤的风险增加约59%（P=0.05, OR=1.59，95% CI：1.00~2.53）。未发现该SNP与川崎病患者静脉注射免疫球蛋白（IVIG）疗效相关联的证据。结论：CASP3基因功能性SNP rs72689236的A等位基因增加了川崎病的发生风险，该SNP的风险等位基因有可能作为川崎病并发冠状动脉损伤的易感遗传标记。目前还没有足够的证据提示该SNP对川崎病的重要治疗手段IVIG的疗效存在影响，需要更多的相关研究以进一步评价其应用于临床个体化治疗方案选择的可行性。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	彭茜
	陈昌辉
	吴青
	杨元

关键词 ：川崎病, 冠状动脉损伤, 静脉注射免疫球蛋白, 半胱氨酸蛋白酶3基因, Meta分析

Abstract：OBJECTIVE: To investigate the association of rs72689236, a new functional single nucleotide polymorphism (SNP) of the gene encoding caspase-3 (CASP3), with the occurrence and development of Kawasaki disease by a meta analysis. METHODS: A literature search was performed using databases at home and abroad according to inclusion and exclusion criteria, to acquire studies on the relationship between rs72689236 and Kawasaki disease published up to November 2012, including casecontrol studies and transmission disequilibrium tests. An integrated meta analysis was performed using RevMan 5.1 software after the studies were screened and evaluated. RESULTS: Six studies were extracted for systematic review of the association between rs72689236 and Kawasaki disease. The frequency of allele A of the SNP was significantly higher in patients with Kawasaki disease than in the controls (OR=1.34, 95%CI=1.24-1.46, P<0.001); the risk for Kawasaki disease in children with allele A (AA+AG) increased by approximately 44% compared with children with GG (OR=1.44, 95%CI=1.27-1.65, P<0.001). The frequency of allele A of the SNP was significantly higher in Kawasaki disease patients with coronary artery lesions than in those without coronary artery lesions (OR=1.51, 95%CI=1.10-2.07, P= 0.01); the risk for coronary artery lesions in Kawasaki disease patients with allele A (AA+AG) increased by approximately 59% compared with Kawasaki disease patients with GG (OR=1.59, 95%CI= 1.00-2.53, P=0.05］. No association between this SNP and the therapeutic effect of intravenous immunoglobulin (IVIG) was found in patients with Kawasaki disease. CONCLUSIONS: The allele A of functional SNP rs72689236 of CASP3 increases the risk for Kawasaki disease, and it may be used as the genetic marker for susceptibility to coronary artery lesions as a complication of Kawasaki disease. Currently, there is still no sufficient evidence that this SNP has an impact on the therapeutic effect of IVIG in patients with Kawasaki disease, and more studies are needed to investigate the feasibility of its application in individualized treatment.

Key words： Kawasaki disease Coronary artery lesion Intravenous immunoglobulin CASP3 Meta analysis

引用本文:

彭茜,陈昌辉,吴青等. CASP3基因一个新的功能性SNP rs72689236与川崎病相关性的Meta分析[J]. 中国当代儿科杂志, 2013, 15(6): 477-483.

PENG Qian,CHEN Chang-Hui,WU Qing et al. Association of new functional SNP rs72689236 of CASP3 with Kawasaki disease: a meta-analysis[J]. CJCP, 2013, 15(6): 477-483.

链接本文:

http://www.zgddek.com/CN/10.7499/j.issn.1008-8830.2013.06.019 或 http://www.zgddek.com/CN/Y2013/V15/I6/477

	［1］Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association［J］. Pediatrics, 2004, 114 (6): 1708-1733.
	［2］Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children［J］. Arerugi, 1967, 16 (3):178-222.
	［3］Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients［J］. Circulation, 1996, 94 (6): 1379-1385.
	［4］Onouchi Y. Molecular genetics of Kawasaki disease［J］. Pediatr Res, 2009, 65 (5 Pt 2): 46R-54R.
	［5］Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T, et al. Common variants in CASP3 confer susceptibility to Kawasaki disease［J］. Hum Mol Genet, 2010, 19 (14): 2898-2906.
	［6］Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms［J］. Nature Genet, 2008, 40 (1): 35-42.
	［7］The Japan Kawasaki Disease Research Committee. Diagnostic Guidelines Of Kawasaki Disease (5th Revised Edition)［DB/OL］. ［2002-02］. http://www.kawasakidisease.org/diagnostic/index.html.
	［8］Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease［J］. Pediatrics, 2000, 105 (6): e78.
	［9］Horwitz RI, Feinstein AR. Methodologic standards and contradictory results in case-control research［J］. Am J Med, 1979, 66 (4): 556-564.
	［10］Centre for Evidence-based Medicine. Systematic Review (critical appraisal sheet)［DB/OL］. ［2005］. http://www.cebm.net.
	［11］Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease［J］. Nat Genet, 2003, 33 (2): 177-182.
	［12］Gong YG, Wu CN, Xing QH, Zhao XZ, Zhu J, He L. A two-method meta-analysis of Neuregulin 1 (NRG1) association and heterogeneity in schizophrenia［J］. Schizophr Res, 2009, 111 (1-3): 109-114.
	［13］Kuo HC,Yu HR,Juo SH, Yang KD, Wang YS, Liang CD, et al. CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children［J］. J Hum Genet, 2011,56 (2): 161-165.
	［14］Onouchi Y, Suzuki Y, Suzuki H, Terai M, Yasukawa K, Hamada H, et al. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease［J］. Pharmacogenomics J, 2013, 13(1): 52-59.
	［15］彭茜, 陈昌辉, 吴青, 李波, 廖静, 罗彩丹，等. CASP3基因单核苷酸多态性与中国儿童川崎病的相关性研究［J］. 中华医学遗传学杂志, 2013, 30(2): 180-184.
	［16］Hata A, Onouchi Y. Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine［J］. J Hum Genet, 2009, 54 (2): 67-73.
	［17］Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD. Kawasaki disease: infection, immunity and genetics［J］. Pediatr Infect Dis J, 2005, 24 (11): 998-1004.
	［18］Cheung YF, Huang GY, Chen SB, Liu XQ, Xi L, Liang XC, et al. Inflammatory gene polymorphisms and susceptibility to kawasaki disease and its arterial sequelae［J］. Pediatrics, 2008, 122 (3): e608-e614.
	［19］Lin YJ, Wan L, Wu JY, Sheu JJ, Lin CW, Lan YC, et al. HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms［J］. Arthritis Rheum, 2009, 60 (2): 604-610.
	［20］高天霁. 姑表兄弟同患川崎病2例报道［J］. 中国当代儿科杂志, 2012, 14(4): 314-315.
	［21］Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease［J］. Nat Genet, 2011, 43 (12): 1241-1246.
	［22］Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease［J］. Nat Genet, 2012, 44 (5): 517-521.
	［23］Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, Chen MR, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis［J］. Nat Genet, 2012, 44 (5): 522-525.
	［24］Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease［J］. PLoS Genet, 2009, 5(1): e1000319.
	［25］Kim JJ, Hong YM, Sohn S, Jang GY, Ha KS, Yun SW, et al. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease［J］. Hum Genet, 2011, 129(5): 487-495.
	［26］Tsai FJ, Lee YC, Chang JS, Huang LM, Huang FY, Chiu NC, et al. Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study［J］. PLoS One, 2011, 6(2): e16853.